Language
Language
USMCA is the world's leading multinational pharmaceutical technology service company, headquartered in Washington D.C., USA, with 40 employees worldwide, and its business scope covers the United States, China, Europe, South Korea, Australia, Africa and other countries and regions, and has offices in four countries in the world. Our company has strong R&D capabilities. We have developed more than 20 formulations and more than 100 products in research and development, including digestion, cardiovascular, anti-cancer, central nervous system, respiratory, and anti-infection. The company has established extensive cooperation with the US FDA, NIH, CDC, top universities, etc., and has great technical capabilities in new molecules, 505(b)(2), orphan drugs, first generic drugs and other projects. The U.S. regulatory team has obtained more than 680 new drug approvals in the United States. At the same time, the company has established in-depth cooperation with a number of overseas pharmaceutical distributors, which can help companies quickly develop international markets and achieve rapid sales and market occupation.
USMCA has a number of cooperative factories in the Chinese and American markets, which can provide a variety of medical outsourcing service classifications, including but not limited to:
Classification | Instruction |
CRA | Taking the contract as the link and undertakes the services in the medical registration process in the form of outsourcing. |
CRO | Authorized by signing a contract to perform certain duties and tasks in the bid for clinical trials. |
CSO | Signing contracts with pharmaceutical manufacturers to obtain sales rights and complete the development of the international market. |
CMO | Accepts the entrustment of pharmaceutical companies to provide various services required during the production of products. |
CDMO | On the basis of CMO, CDMO provides R&D and optimization of process flow, formulation development and trial production services required for the production of innovative drugs, and further provides customized production services. |
We also provide solutions for the entire industry supply chain：
Raw Materials | Pharmaceutical R&D and Manufacturing | Medicine Circulation |
Animal and plant materials | Biological Products | Medical warehousing |
Pharmaceutical excipients and packaging materials | Chemical Products | Pharmaceutical logistics (General logistics, cold chain logistics, dangerous goods logistics) |
Fine chemical materials | Traditional Chinese Medicine Products | Hospitals and retail pharmacies |
Bulk API | Genetically engineered pharmaceuticals and vaccines | Patient Groups |
Special API | Veterinary medicine | |
Patented API | Other medicines |
USMCA adheres to the concept of "based on the world, long-term development", long-term planning, long-term investment, rooted in international medical technology services, and is committed to strengthening cooperation with local Chinese pharmaceutical companies and the global pharmaceutical market.
中文版
English
